Medijski sadržaj
- Tweetovi
- Tweetovi i odgovori
- Medijski sadržaj, trenutna stranica.
-
After Merck spins out slower-growing businesses to focus on innovation, the company will need recent and future deals to yield fruit in order to balance its reliance on Keytruda for growth
$MRK https://buff.ly/31t3QqR pic.twitter.com/Tk8AKxjq6O
-
FDA's Richard Pazdur supports expanded access for unapproved uses of approved drugs https://buff.ly/2GXUU3h pic.twitter.com/fdIfJPOQQy
-
EMA hopes to lower barriers to use of real-world data in regulatory decision making by creating a centralized system for integrating RWD across Europe. https://buff.ly/2GUgoho pic.twitter.com/uEML8Qo1Qb
-
Digital health technologies offer promise for the research and development of new drugs. Register now for the FNIH workshop exploring challenges & opportunities for remote digital monitoring on 2/18-2/19: http://bit.ly/2tMGZcW pic.twitter.com/Wy9plE07xn
-
Registration now open for Bio€quity Europe, showcasing 90+ presentations from rising biotechs. Meet our team at
#jpm20 https://bit.ly/2RdJmgX pic.twitter.com/xabbe5fvaO
-
We are honored to collaborate with
@News1Kr to provide a Korean language version of top BioCentury stories for local biopharma executives and investors. The signing ceremony was held Nov. 25 in Seoul. http://news1.kr/articles/?3778043 …pic.twitter.com/zQdpHlBCpc
-
Congrats to the 2019 BayHelix China Healthcare Award winners, announced last week during the 6th BioCentury-BayHelix China Healthcare Summit in Shanghai.
$BGNE$AMGN$FGEN$ZLAB https://www.biocentury.com/conferences/china-healthcare-summit-2019?scroll_anchor=award_winners …pic.twitter.com/zxGOiOuCQJ
-
Early Bird Deadline is Sunday for 6th BioCentury-BayHelix China Healthcare Summit. Record attendance expected. Strategic panels. Road Show track. McKinsey report. 1x1 meetings. Awards banquet. C-suite networking. Register today: https://www.cvent.com/events/biocentury-and-bayhelix-present-the-2019-china-healthcare-summit/registration-0ad14adc9ee54b7f9c3e92e7b4334f63.aspx?fqp=true …pic.twitter.com/VwRRbjTi6A
-
This year, BioCentury's Back To School essay argues that it's time for the biopharma industry to write the rules of the road for
#DigitalHealth. Part 1 of#BCBackToSchool https://buff.ly/2ZKjaB6 pic.twitter.com/H8eORrY4Gd
-
The first rule for
#DigitalHealth should be that patients can control who has access to their data and how it can be used, argues@BioCentury in Part 2 of the#BCBackToSchool essay. https://buff.ly/2ZuEFq0 pic.twitter.com/AcW2S9AzVY
-
In
#DigitalHealth, defining what is and isn't regulated will mean re-examining concepts like "identity" and "quality" for products that are continually changing. Part 3 of the#BCBackToSchool essay. https://buff.ly/34ddcaZ pic.twitter.com/QMcmaH2OEB
-
In
#DigitalHealth, companies need to go back to first principles to think about placebos, validation, statistical models and more. Part 4 of#BCBackToSchool https://buff.ly/2LhlEO1 pic.twitter.com/sbNLBgtuTZ
-
Case studies on first movers in
#DigitalHealth making inroads into biotech#BCBackToSchool https://buff.ly/2NGIqBC pic.twitter.com/NcHNYR8cQK
-
Payers are, like everyone, at square 1 in
#DigitalHealth: the Q for them - what evidence will constitute a measurable benefit?#BCBackToSchool2019 https://buff.ly/2ZLtzsc pic.twitter.com/zbYoIZPm3e
-
Most pharmas and big biotechs are testing the waters in#digitalhealth and some have taken the full plunge. A snapshot of activity. https://buff.ly/2ZId3ZI pic.twitter.com/KuIMhYVmVF
-
BioCentury's survey of financing for
#DigitalHealth companies shows over $2 billion raised since 2013 for digital therapeutics, biomarkers and tools for disease management.#BCBacktoSchool https://buff.ly/30ThuCE pic.twitter.com/Ie8TJeio2K
-
Build cross-border relationships and find your next strategic partner at the BioCentury-BayHelix China Healthcare Summit. Early-Bird discount ends Sept. 15. https://bit.ly/2M99UQy pic.twitter.com/Wvqd3eQzs0
-
Time’s running out for Western biotech execs and investors to register for the BioCentury-BayHelix China Healthcare Summit. This is a unique opportunity to network with key industry stakeholders from China, Asia and the West in an intimate, VIP setting. https://bit.ly/2M99UQy pic.twitter.com/GXzB9p0SnA
-
NewsMakers returns with a program focused on understanding and managing today’s investment risk. Initial slate of Presenting Companies just announced https://bit.ly/2K8J5K2
#NewsMakers@ABScience_US@BridgeBiorx@EurekaThera@HookipaPharma@KymeraTx@Myovantpic.twitter.com/Ptl7rRaSkS
-
Full program and faculty announced
#BioEquity (Barcelona, May 20-21). Register now to learn which EU innovation centers are leading the pack, hear from 80+ hand-picked biotechs, and network with our audience of C-level execs and investment decision makers https://buff.ly/2WA23gk pic.twitter.com/ja8IhwfC5L
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.